We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
Already have an account? Sign in.

 Remember Me | Forgot Your Password?

FDA Approves Nutritional Ingredient That Enhances Coronary Blood Flow

May 17, 2013: 12:00 AM EST
After approval of Nitrosigine by the FDA as a New Dietary Ingredient, functional nutrition ingredients maker Nutrition 21 has begun marketing the source of inositol-stabilized arginine silicate demonstrated to significantly improve coronary blood flow. In preclinical studies, Nitrosigine demonstrated superiority over arginine in blood flow markers and silicon absorption. Arginine is a natural metabolic donor of nitric oxide, while silicon benefits connective tissue and bone health. Nitrosigine will be marketed to dietary supplement providers in the sports nutrition, cardiovascular health and men’s health categories. Results of a clinical study are expected in the third quarter of this year.
"Nutrition 21 Unveils NDI Nitrosigine", Nutraceuticals World, May 17, 2013, © Rodman Media
North America
United States of America
Companies, Organizations
Innovation & New Ideas
Products & Brands
Developed by Yuri Ingultsov Software Lab.